Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant-Reference-Cited by-同舟云学术

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant

Published:2016-10-06 Issue:2 Volume:102 Page:401-410
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Ruggeri Annalisa,Sun Yuqian,Labopin Myriam,Bacigalupo Andrea,Lorentino Francesca,Arcese William,Santarone Stella,Gülbas Zafer,Blaise Didier,Messina Giuseppe,Ghavamzadeh Ardeshi,Malard Florent,Bruno Benedetto,Diez-Martin Jose Luis,Koc Yener,Ciceri Fabio,Mohty Mohamad,Nagler Arnon

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant cyclophosphamide plus anti-thymocyte globulin lowered serum IL-6 levels compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation;2024-09-11

2. Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia;Annals of Hematology;2024-08-17

3. High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention;Blood Advances;2024-08-15

4. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT;Blood Advances;2024-07-26

5. Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis;Transplantation and Cellular Therapy;2024-07